Role of Histamine H3 Receptor Antagonist Pitolisant in Early Neural Differentiation of Mouse Embryonic Stem Cells.

Stem cells and development Pub Date : 2024-02-01 Epub Date: 2024-01-08 DOI:10.1089/scd.2023.0162
Genghua Xu, Nuoya Liu, Yaqing Qiu, Jiayu Qi, Danyan Zhu
{"title":"Role of Histamine H<sub>3</sub> Receptor Antagonist Pitolisant in Early Neural Differentiation of Mouse Embryonic Stem Cells.","authors":"Genghua Xu, Nuoya Liu, Yaqing Qiu, Jiayu Qi, Danyan Zhu","doi":"10.1089/scd.2023.0162","DOIUrl":null,"url":null,"abstract":"<p><p>The histamine H<sub>3</sub> receptor, prominently expressed in neurons with a minor presence in glial cells, acts as both an autoreceptor and an alloreceptor, controlling the release of histamine and other neurotransmitters. The receptor impacts various essential physiological processes. Our team's initial investigations had demonstrated that the histamine H<sub>3</sub> receptor antagonists could facilitate nerve regeneration by promoting the histamine H<sub>1</sub> receptors on primary neural stem cells (NSCs) in the traumatic brain injury mouse, which suggested the potential of histamine H<sub>3</sub> receptor as a promising target for treating neurological disorders and promoting nerve regeneration. Pitolisant (PITO) is the only histamine H<sub>3</sub> receptor antagonist approved by the Food and Drug Administration (FDA) for treating narcolepsy. However, there is no report on Pitolisant in neural development or regeneration, and it is urgent to be further studied in strong biological activity models in vitro. The embryonic stem (ES) cells were differentiated into neural cells in vitro, which replicated the neurodevelopmental processes that occur in vivo. It also provided an alternative model for studying neurodevelopmental processes and testing drugs for neurological conditions. Therefore, we aimed to elucidate the regulatory role of Pitolisant in the early differentiation of ES cells into neural cells. Our results demonstrated that Pitolisant could promote the differentiation of ES cells toward NSCs and stimulated the formation of growth cones. Furthermore, Pitolisant was capable of inducing the polarization of NSCs through the cAMP-LKB1-SAD/MARK2 pathway, but had no significant effect on later neuronal maturation. Pitolisant altered mitochondrial morphology and upregulated the levels of mitochondrion-related proteins TOM20, Drp1, and p-Drp1, and reversed the inhibitory effect of Mdivi-1 on mitochondrial fission during the early neural differentiation of ES cells. In addition, Pitolisant induced the increase in cytosolic Ca<sup>2+</sup>. Our study provided an experimental foundation for the potential application of histamine H<sub>3</sub> receptor-targeted modulators in the field of neuroregeneration.</p>","PeriodicalId":94214,"journal":{"name":"Stem cells and development","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stem cells and development","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/scd.2023.0162","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/8 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The histamine H3 receptor, prominently expressed in neurons with a minor presence in glial cells, acts as both an autoreceptor and an alloreceptor, controlling the release of histamine and other neurotransmitters. The receptor impacts various essential physiological processes. Our team's initial investigations had demonstrated that the histamine H3 receptor antagonists could facilitate nerve regeneration by promoting the histamine H1 receptors on primary neural stem cells (NSCs) in the traumatic brain injury mouse, which suggested the potential of histamine H3 receptor as a promising target for treating neurological disorders and promoting nerve regeneration. Pitolisant (PITO) is the only histamine H3 receptor antagonist approved by the Food and Drug Administration (FDA) for treating narcolepsy. However, there is no report on Pitolisant in neural development or regeneration, and it is urgent to be further studied in strong biological activity models in vitro. The embryonic stem (ES) cells were differentiated into neural cells in vitro, which replicated the neurodevelopmental processes that occur in vivo. It also provided an alternative model for studying neurodevelopmental processes and testing drugs for neurological conditions. Therefore, we aimed to elucidate the regulatory role of Pitolisant in the early differentiation of ES cells into neural cells. Our results demonstrated that Pitolisant could promote the differentiation of ES cells toward NSCs and stimulated the formation of growth cones. Furthermore, Pitolisant was capable of inducing the polarization of NSCs through the cAMP-LKB1-SAD/MARK2 pathway, but had no significant effect on later neuronal maturation. Pitolisant altered mitochondrial morphology and upregulated the levels of mitochondrion-related proteins TOM20, Drp1, and p-Drp1, and reversed the inhibitory effect of Mdivi-1 on mitochondrial fission during the early neural differentiation of ES cells. In addition, Pitolisant induced the increase in cytosolic Ca2+. Our study provided an experimental foundation for the potential application of histamine H3 receptor-targeted modulators in the field of neuroregeneration.

组胺H3受体拮抗剂Pitolisant在小鼠胚胎干细胞早期神经分化中的作用。
组胺H3受体主要在神经元中表达,少量存在于神经胶质细胞中,它既是自身受体又是同种异体受体,控制着组胺和其他神经递质的释放。受体影响各种重要的生理过程。我们团队的初步研究表明,组胺H3受体拮抗剂可以通过促进创伤性脑损伤小鼠原代神经干细胞上的组胺H1受体促进神经再生,这表明组胺H3受体可能是治疗神经系统疾病和促进神经再生的一个有希望的靶点。Pitolisant (PITO)是唯一被FDA批准用于治疗嗜睡症的组胺H3受体拮抗剂。然而,目前尚无关于Pitolisant在神经发育或再生中的报道,迫切需要在体外强生物活性模型中进一步研究。胚胎干细胞(ES)在体外分化为神经细胞,复制了体内发生的神经发育过程。它还为研究神经发育过程和测试神经疾病药物提供了另一种模型。因此,我们旨在阐明Pitolisant在胚胎干细胞早期分化为神经细胞中的调节作用。结果表明,Pitolisant能够促进胚胎干细胞向神经干细胞(NSCs)的分化,并刺激生长锥的形成。此外,Pitolisant能够通过camp - lk_1 - sad /MARK2通路诱导NSCs的极化,但对后期神经元成熟无显著影响。Pitolisant改变了线粒体形态,上调了线粒体相关蛋白TOM20、Drp1和p-Drp1的水平,逆转了Mdivi-1对ES细胞早期神经分化过程中线粒体分裂的抑制作用。此外,Pitolisant诱导细胞质Ca2+的增加。本研究为组胺H3受体靶向调节剂在神经再生领域的潜在应用提供了实验基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信